Vaccine Development

Pfizer, once hailed globally for pioneering the first FDA-approved Covid vaccine, is witnessing a dramatic shift in its fortunes. At its peak during the pandemic, the pharmaceutical giant’s market value soared to $333.8 billion. Fast forward to now, its valuation has plummeted